SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-011383
Filing Date
2023-03-31
Accepted
2023-03-31 16:13:14
Documents
3
Period of Report
2023-05-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A ktra_def_14a_2023_agm.htm DEF 14A 933187
2 GRAPHIC img85866569_0.jpg GRAPHIC 252055
3 GRAPHIC img85866569_1.jpg GRAPHIC 330267
  Complete submission text file 0000950170-23-011383.txt   1736632
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-37823 | Film No.: 23787783
SIC: 2834 Pharmaceutical Preparations